nivolumab,ipilimumab
BMS
['lcsm,(-blcsm)', 'nsclc', 'sclc', 'increase,(-increased)']
increase; induction chemo-2io-rt preop in borderline resectable nsclc; very high % of pdl1 high; pcr 55%; mpr 70%; (63% and 79% in operated) #esmo22 #lcsm 
Consultant Medical Oncologist, UK. Views are hypothesis generating discourse. Post COVID dabbling in garden.